This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 24/3/613    most recent 01.ATV.0000116026.18945.66v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Keuren, J. F.W. Articles by Lindhout, T. Search for Related Content PubMed PubMed Citation Articles by Keuren, J. F.W. Articles by Lindhout, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HEPARIN Related Collections Coagulation Thrombin Coagulation inhibitors Heparin Platelets

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:613.)
© 2004 American Heart Association, Inc.

Thrombosis

Covalently-Bound Heparin Makes Collagen Thromboresistant

Jeffrey F.W. Keuren; Simone J.H. Wielders; Anita Driessen; Michel Verhoeven; Marc Hendriks; Theo Lindhout

From the Department of Biochemistry (J.F.W.K., T.L.) and the Cardiovascular Research Institute (S.J.H.W., T.L.), Maastricht University, 6200 MD Maastricht, The Netherlands; and the Medtronic Bakken Research Center B.V. (A.D., M.V., M.H.), 6229 GW Maastricht, The Netherlands.

Correspondence to Dr. T. Lindhout, Department of Biochemistry, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. E-mail t.lindhout{at}bioch.unimaas.nl

Objective— Blood compatibility of artificial surfaces depends on their immunogenic and thrombogenic properties. Collagen’s weak antigenicity makes it an attractive candidate for stent coatings or fabrication of vascular grafts. However, the thrombogenic nature of collagen limits its application. We examined whether heparinization can make collagen more thromboresistant.

Methods and Results— Collagen was heparinized by crosslinking collagen with extensively periodate oxidized heparin and/or by covalently bonding of mildly periodate oxidized heparin. Both ways of heparinization have no effect on platelet adhesion and could not abolish induction of platelet procoagulant activity. However, thrombin generation was completely prevented under static and flow conditions. The functionality of immobilized heparin was confirmed by specific uptake of antithrombin, 13.5±4.7 pmol/cm² and 1.95±0.21 pmol/cm² for mildly and heavily periodated heparin, respectively.

Conclusions— These results indicate that immobilization of heparin on collagen, even as a crosslinker, is a very effective way to prevent surface thrombus formation. These data encourage the application of heparinized collagen as stent-graft material in animal and eventually human studies.

Key Words: collagen • heparin • thrombogenicity • thrombosis • blood flow

This article has been cited by other articles:

				D. R. Whittaker and M. F. Fillinger The Engineering of Endovascular Stent Technology: A Review Vascular and Endovascular Surgery, March 1, 2006; 40(2): 85 - 94. [Abstract] [PDF]